Occurrence of HAEC · children with Hirschsprung's disease (HD)
It is very uncertain whether probiotics changes occurrence of HAEC compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · children with Hirschsprung's disease (HD)
1 finding from 1 review
Severity of HAEC Â · children with Hirschsprung's disease (HD)
Probiotics showed no clear difference in severity of HAEC Â compared with placebo (low certainty).
1 finding from 1 review
Overall mortality · children with Hirschsprung's disease (HD)
1 finding from 1 review
Withdrawals due to adverse events · children with Hirschsprung's disease (HD)
1 finding from 1 review
Recurrent episodes of HAEC · children with Hirschsprung's disease (HD)
Probiotics showed no clear difference in recurrent episodes of HAEC compared with placebo (low certainty).
1 finding from 1 review
Clinical remission · people with active UC
Probiotics may leads to higher clinical remission compared with placebo (low certainty).
1 finding from 1 review
Disease improvement (based on clinical scores) · people with active UC
Probiotics may leads to higher disease improvement (based on clinical scores) compared with placebo (low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
It is very uncertain whether probiotics changes minor adverse events compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events · people with active UC
It is very uncertain whether probiotics changes serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
Probiotics showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Remission · induction of remission in Crohn's disease
It is very uncertain whether probiotics changes induction of remission compared with placebo (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · induction of remission in Crohn's disease
It is very uncertain whether probiotics changes adverse events leading to withdrawal compared with placebo (very low certainty).
1 finding from 1 review
Clinical relapse · Patients with quiescent ulcerative colitis
It is very uncertain whether probiotics changes clinical relapse (12 to 52 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Maintenance of clinical remission · Patients with quiescent ulcerative colitis
It is very uncertain whether probiotics changes maintenance of clinical remission (52 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events (48 to 52 weeks) · Patients with quiescent ulcerative colitis
1 finding from 1 review
Withdrawals due to adverse events · Patients with quiescent ulcerative colitis
1 finding from 1 review
Need for extra treatment · Patients with quiescent ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life (12 weeks) · Patients with quiescent ulcerative colitis
1 finding from 1 review
Clinical response · Patients with collagenous colitis
It is very uncertain whether probiotics changes clinical response compared with placebo (very low certainty).
1 finding from 1 review